BAFF protein (Active) (ab83938)
Constituents: 10% Trehalose, 1% Human serum albumin
Our Abpromise guarantee covers the use of ab83938 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ab83938 migrates as a band between 15 and 20 kDa in SDS-PAGE. This compares with the predicted molecular mass of 17 kDa.
Due to post-translational modifications ab83938 separates into a number of glycoforms with a pI between 4.7 and 5.5 on 2D PAGE. This is in agreement with the unmodified BAFF that has a predicted pI of 4.9.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
- ApoL related ligand TALL 1B cell Activating FactorB lymphocyte stimulator
- B-cell-activating factorBAFFBLYSCD 257CD257CD257 antigendelta BAFFDendritic cell derived TNF like moleculeDendritic cell-derived TNF-like moleculeDTLDTL precursorPRO738soluble formTALL 1TALL-1TALL1THANKTN13B_HUMANTNF and APOL related leukocyte expressed ligand 1TNF homolog that activates apoptosisTNF homolog that activates apoptosis NKFB and JNK.TNF- and APOL-related leukocyte expressed ligand 1TNFSF13BTNFSF20Tumor necrosis factor ligand superfamily member 13BTumor necrosis factor ligand superfamily member 20Tumor necrosis factor like protein ZTNF4Tumor necrosis factor superfamily member 13BUNQ401ZTNF4
modificationsThe soluble form derives from the membrane form by proteolytic processing.
BAFF protein (Active) images
Post-translational modifications result in protein heterogeneity. The densitometry scan demonstrates the purified human cell expressed protein exists in multiple glycoforms, which differ according to their level of post-translational modification. The triangle indicates theoretical pI and MW of the protein.
References for BAFF protein (Active) (ab83938)
ab83938 has not yet been referenced specifically in any publications.